PART I . Overview Protagenic Therapeutic, Inc. (together with its subsidiary, Protagenic, the Company, we, our or us) are a biopharmaceutical company specializing in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Our proprietary, patent-protected, first-in-class lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide (TCAP), an endogenous brain signaling peptide that can dampen overactive stress respo...
Q2 FY2026 — expected 2026-08-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-31 | 2024-12-31 | 0001641172-25-001600 | EDGAR | 62K words |
| 2024-04-01 | 2023-12-31 | 0001493152-24-012333 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001493152-23-010152 | EDGAR | — |
| 2022-04-07 | 2021-12-31 | 0001493152-22-009370 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001493152-21-006756 | EDGAR | — |
| 2020-04-29 | 2019-12-31 | 0001493152-20-007286 | EDGAR | — |
| 2019-03-29 | 2018-12-31 | 0001493152-19-004288 | EDGAR | — |
| 2018-04-02 | 2017-12-31 | 0001493152-18-004567 | EDGAR | — |
| 2017-04-18 | 2016-12-31 | 0001437749-17-006686 | EDGAR | — |
| 2015-09-25 | 2015-06-30 | 0001144204-15-056587 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001493152-26-009301 | EDGAR | 28K words |
| 2025-11-26 | 2025-09-30 | 0001493152-25-025201 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001641172-25-009923 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001493152-24-045913 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001493152-24-032349 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001493152-24-019933 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001493152-23-041032 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001493152-23-028345 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001493152-23-017171 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001493152-22-031862 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001493152-22-022069 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001493152-22-013159 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-03 | 0001493152-26-008605 | EDGAR | 1K words |
| 2026-02-24 | 0001493152-26-007800 | EDGAR | — |
| 2026-01-05 | 0001493152-26-000263 | EDGAR | — |
| 2025-11-26 | 0001493152-25-025159 | EDGAR | — |
| 2025-11-05 | 0001493152-25-020881 | EDGAR | — |
| 2025-10-31 | 0001493152-25-020444 | EDGAR | — |
| 2025-08-22 | 0001641172-25-025274 | EDGAR | — |
| 2025-08-13 | 0001641172-25-023588 | EDGAR | — |
| 2025-07-30 | 0001641172-25-021552 | EDGAR | — |
| 2025-07-24 | 0001641172-25-020802 | EDGAR | — |
301 total filings indexed. 269 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001022899 |
| Ticker | PTIX |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PTIX (~200 tokens, structured JSON with cryptographic provenance)